GBGunnar Brix

Gunnar Brix

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gunnar Brix has a total of 169 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Improving pulmonary perfusion assessment by dynamic contrast-enhanced computed tomography in an experimental lung injury model

    by Yi Xin, Taehwan Kim, Tilo Winkler, Gunnar Brix, Timothy Gaulton, Sarah E. Gerard, Jacob Herrmann, Kevin T. Martin, Marcus Victor, Kristan Reutlinger, et al.

    Dynamic contrast-enhanced CT using a lower-viscosity contrast agent in combination with tracer-kinetic analysis by the steepest-slope model improves pulmonary blood flow measurements and assessment of regional distributions of lung perfusion.


  • Nuklearmedizinische Strahlenexpositionen während der Schwangerschaft

    by Christian Happel, Markus Borowski, Daniel Gröner, Alexandra Kamp, Gunnar Brix, Frank Grünwald, Martin Fiebich

    In medizinisch begründeten Einzelfällen oder bei unbekannter Frühschwangerschaft kann es durch die Applikation offener radioaktiver Stoffe in der Nuklearmedizin zu einer pränatalen Strahlenexposition kommen. Die von Metabolisierung und Biodistribution abhängende Dosis für das Ungeborene kann messtechnisch nicht ermittelt werden. Eine möglichst valide Abschätzung der Dosis ist daher von großer Relevanz. Die Abschätzung erfolgt üblicherweise mit den biokinetischen und dosimetrischen Modellen der ICRP. Bei der Hybridbilddiagnostik muss zusätzlich auch die Strahlenexposition durch die radiologische Komponente berücksichtigt werden. Die Aktivität der im Rahmen einer nuklearmedizinischen Diagnostik applizierten offenen radioaktiven Stoffe führt üblicherweise zu einer Dosis des Ungeborenen von weniger als 20mSv. Relevante deterministische Strahlenwirkungen sind hier auszuschließen. Es ergeben sich keine praktischen Konsequenzen für den weiteren Verlauf der Schwangerschaft. Bei höheren Dosiswerten für das Ungeborene, wie sie insbesondere bei der therapeutischen Anwendung offener radioaktiven Stoffe bei unbekannter Schwangerschaft auftreten können, kann jedoch eine Dosis von 100mSv für das Ungeborene überschritten werden, welche als Schwelle für die Induktion von anatomischen Fehlbildungen, Wachstumshemmungen und funktionellen Störungen gilt. In rare medically indicated cases or unknown early pregnancy, incorporation of radionuclides administered for nuclear medicine procedures may lead to prenatal radiation exposure. The dose to the unborn depends on metabolization and biodistribution and cannot be directly measured. A valid estimation of the dose is therefore highly relevant. The estimation is usually performed by means of biokinetic and dosimetric models provided by the ICRP. When hybrid diagnostics are implicated, additional radiation exposure through radiological imaging must be taken into account. The activity administered for standard diagnostic procedures in nuclear medicine results in dose estimates to the unborn below 20mSv. Relevant radiation-induced events are not expected. Dose values beyond 100mSv are expected for administration of therapeutic radiopharmaceuticals, only. This, however, refers to extremely rare situations, when applications are performed without awareness of an existing pregnancy. In these cases induction of anatomical malformation, growth restriction, and functional anomalies cannot be excluded. Article published online: 21 March 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Lung Cancer Screening with Low-Dose CT: Radiation Risk and Benefit–Risk Assessment for Different Screening Scenarios

    by Elke A. Nekolla, Gunnar Brix, Jürgen Griebel

    Lung cancer is a severe disease that affects predominantly smokers and represents a leading cause of cancer death in Europe. Recent meta-analyses of randomized controlled trials (RCTs) have yielded that low-dose computed tomography (LDCT) screening can significantly reduce lung cancer mortality in heavy smokers or ex-smokers by about 20% compared to a control group of persons who did not receive LDCT. This benefit must be weighed against adverse health effects associated with LDCT lung screening, in particular radiation risks. For this purpose, representative organ doses were determined for a volume CT dose index of 1 mGy that can be achieved on modern devices. Using these values, radiation risks were estimated for different screening scenarios by means of sex-, organ-, and age-dependent radio-epidemiologic models. In particular, the approach was adjusted to a Western European population. For an annual LDCT screening of (ex-)smokers aged between 50 and 75 years, the estimated radiation-related lifetime attributable risk to develop cancer is below 0.25% for women and about 0.1% for men. Assuming a mortality reduction of about 20% and taking only radiation risks into account, this screening scenario results in a benefit–risk ratio of about 10 for women and about 25 for men. These benefit–risk ratio estimates are based on the results of RCTs of the highest evidence level. To ensure that the benefit outweighs the radiation risk even in standard healthcare, strict conditions and requirements must be established for the entire screening process to achieve a quality level at least as high as that of the considered RCTs.


  • Open Access

    Lung Cancer Screening with Low-Dose CT in Smokers: A Systematic Review and Meta-Analysis

    by Theresa Hunger, Eva Wanka-Pail, Gunnar Brix, Jürgen Griebel

    Lung cancer continues to be one of the main causes of cancer death in Europe. Low-dose computed tomography (LDCT) has shown high potential for screening of lung cancer in smokers, most recently in two European trials. The aim of this review was to assess lung cancer screening of smokers by LDCT with respect to clinical effectiveness, radiological procedures, quality of life, and changes in smoking behavior. We searched electronic databases in April 2020 for publications of randomized controlled trials (RCT) reporting on lung cancer and overall mortality, lung cancer morbidity, and harms of LDCT screening. A meta-analysis was performed to estimate effects on mortality. Forty-three publications on 10 RCTs were included. The meta-analysis of eight studies showed a statistically significant relative reduction of lung cancer mortality of 12% in the screening group (risk ratio = 0.88; 95% CI: 0.79–0.97). Between 4% and 24% of screening-LDCT scans were classified as positive, and 84–96% of them turned out to be false positive. The risk of overdiagnosis was estimated between 19% and 69% of diagnosed lung cancers. Lung cancer screening can reduce disease-specific mortality in (former) smokers when stringent requirements and quality standards for performance are met.


  • Open Access

    COPD Imaging on a 3rd Generation Dual-Source CT: Acquisition of Paired Inspiratory-Expiratory Chest Scans at an Overall Reduced Radiation Risk

    by Joshua Gawlitza, Thomas Henzler, Frederik Trinkmann, Elke Nekolla, Holger Haubenreisser, Gunnar Brix

    As stated by the Fleischner Society, an additional computed tomography (CT) scan in expiration is beneficial in patients with chronic obstructive pulmonary disease (COPD). It was thus the aim of this study to evaluate the radiation risk of a state-of-the-art paired inspiratory-expiratory chest scan compared to inspiration-only examinations. Radiation doses to 28 organs were determined for 824 COPD patients undergoing routine chest examinations at three different CT systems–a conventional multi-slice CT (MSCT), a 2nd generation (2nd-DSCT), and 3rd generation dual-source CT (3rd-DSCT). Patients examined at the 3rd-DSCT received a paired inspiratory-expiratory scan. Organ doses, effective doses, and lifetime attributable cancer risks (LAR) were calculated. All organ and effective doses were significantly lower for the paired inspiratory-expiratory protocol (effective doses: 4.3 ± 1.5 mSv (MSCT), 3.0 ± 1.2 mSv (2nd-DSCT), and 2.0 ± 0.8 mSv (3rd-DSCT)). Accordingly, LAR was lowest for the paired protocol with an estimate of 0.025 % and 0.013% for female and male patients (50 years) respectively. Image quality was not compromised. Paired inspiratory-expiratory scans can be acquired on 3rd-DSCT systems at substantially lower dose and risk levels when compared to inspiration-only scans at conventional CT systems, offering promising prospects for improved COPD diagnosis.


  • Open Access

    Double-strand breaks in lymphocyte DNA of humans exposed to [18F]fluorodeoxyglucose and the static magnetic field in PET/MRI

    by Gunnar Brix, Elisabeth Günther, Ute Rössler, David Endesfelder, Alexandra Kamp, Ambros Beer, Matthias Eiber

    Background: Given the increasing clinical use of PET/MRI, potential risks to patients from simultaneous exposure to ionising radiation and (electro)magnetic fields should be thoroughly investigated as a precaution. With this aim, the genotoxic potential of 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) and a strong static magnetic field (SMF) were evaluated both in isolation and in combination using the γH2AX assay detecting double-strand breaks in lymphocyte DNA. Methods: Thirty-two healthy young volunteers allocated to three study arms were exposed to [18F]FDG alone, to a 3-T SMF alone or to both combined over 60 min at a PET/CT or a PET/MRI system. Blood samples taken after in vivo exposure were incubated up to 60 min to extend the irradiation of blood by residual [18F]FDG within the samples and the time to monitor the γH2AX response. Absorbed doses to lymphocytes delivered in vivo and in vitro were estimated individually for each volunteer exposed to [18F]FDG. γH2AX foci were scored automatically by immunofluorescence microscopy. Results: Absorbed doses to lymphocytes exposed over 60 to 120 min to [18F]FDG varied between 1.5 and 3.3 mGy. In this time interval, the radiotracer caused a significant median relative increase of 28% in the rate of lymphocytes with at least one γH2AX focus relative to the background rate (p = 0.01), but not the SMF alone (p = 0.47). Simultaneous application of both agents did not result in a significant synergistic or antagonistic outcome (p = 0.91). Conclusion: There is no evidence of a synergism between [18F]FDG and the SMF that may be of relevance for risk assessment of PET/MRI.


  • Early Detection of Diseases by Radiological Imaging: New Legal Situation and Evaluation of Service Offers using CT Examinations as an Example

    by Gunnar Brix, Elke Anna Nekolla, Jürgen Griebel

    Background Radiological imaging offers promising prospects for the early detection of diseases. In Germany, the legal framework for such examinations was created by the Radiation Protection Law, which entered into force on December 31, 2018. Under this law, each specific type of radiodiagnostic screening of non-communicable diseases needs an approval on a generic level (permission) by a federal statutory ordinance, defining the specific requirements and conditions. It is the aim of the present paper, (i) to present in detail the new legal situation and (ii) to assess actual service offers for the screening of asymptomatic persons using CT examinations as an example. Method In February 2019, radiology institutions in Germany illegally offering on the Internet CT examinations for the screening of lung and colon cancer or coronary artery disease were identified. For each type of examination, 50 pertinent websites were evaluated particularly regarding the general information on the offered screening examination and the concrete procedure. Results In the vast majority of cases, the information provided on the websites was inadequate and disproportionately emphasized the benefits over the risks of the screening examination. Moreover, the offers differed substantially with respect to the age and risks factors of potential participants, the frequency of examinations, the screening procedure, and the diagnostic workup. Conclusion The evaluated service offers strongly substantiate the need to define requirements and conditions regarding radiological screening examinations by statutory ordinances, in order to ensure an informed decision of potential screening participants as well as the benefit versus the risks of the procedures.


  • Two‐compartment modeling of tissue microcirculation revisited

    by Gunnar Brix, Mona Salehi Ravesh, Jürgen Griebel

    Purpose: Conventional two‐compartment modeling of tissue microcirculation is used for tracer kinetic analysis of dynamic contrast‐enhanced (DCE) computed tomography or magnetic resonance imaging studies although it is well‐known that the underlying assumption of an instantaneous mixing of the administered contrast agent (CA) in capillaries is far from being realistic. It was thus the aim of the present study to provide theoretical and computational evidence in favor of a conceptually alternative modeling approach that makes it possible to characterize the bias inherent to compartment modeling and, moreover, to approximately correct for it.Methods: Starting from a two‐region distributed‐parameter model that accounts for spatial gradients in CA concentrations within blood‐tissue exchange units, a modified lumped two‐compartment exchange model was derived. It has the same analytical structure as the conventional two‐compartment model, but indicates that the apparent blood flow identifiable from measured DCE data is substantially overestimated, whereas the three other model parameters (i.e., the permeability‐surface area product as well as the volume fractions of the plasma and interstitial distribution space) are unbiased. Furthermore, a simple formula was derived to approximately compute a bias‐corrected flow from the estimates of the apparent flow and permeability‐surface area product obtained by model fitting. To evaluate the accuracy of the proposed modeling and bias correction method, representative noise‐free DCE curves were analyzed. They were simulated for 36 microcirculation and four input scenarios by an axially distributed reference model.Results: As analytically proven, the considered two‐compartment exchange model is structurally identifiable from tissue residue data. The apparent flow values estimated for the 144 simulated tissue/input scenarios were considerably biased. After bias‐correction, the deviations between estimated and actual parameter values were (11.2 ± 6.4) % (vs. (105 ± 21) % without correction) for the flow, (3.6 ± 6.1) % for the permeability‐surface area product, (5.8 ± 4.9) % for the vascular volume and (2.5 ± 4.1) % for the interstitial volume; with individual deviations of more than 20% being the exception and just marginal. Increasing the duration of CA administration only had a statistically significant but opposite effect on the accuracy of the estimated flow (declined) and intravascular volume (improved).Conclusions: Physiologically well‐defined tissue parameters are structurally identifiable and accurately estimable from DCE data by the conceptually modified two‐compartment model in combination with the bias correction. The accuracy of the bias‐corrected flow is nearly comparable to that of the three other (theoretically unbiased) model parameters. As compared to conventional two‐compartment modeling, this feature constitutes a major advantage for tracer kinetic analysis of both preclinical and clinical DCE imaging studies.